Literature DB >> 19969034

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

Mathieu Mével1, Nazila Kamaly, Sergio Carmona, Morag H Oliver, Michael R Jorgensen, Carol Crowther, Felix H Salazar, Patricia L Marion, Masato Fujino, Yukikazu Natori, Maya Thanou, Patrick Arbuthnot, Jean-Jacques Yaouanc, Paul Alain Jaffrès, Andrew D Miller.   

Abstract

We report the syntheses of novel cationic lipids comprised of cholesteryl-moieties linked to guanidinium functional groups, and also cationic lipids comprising a dialkylglycylamide moiety conjugated with a polyamine or a guanidinium functional group. In plasmid DNA (pDNA) transfection studies, these cationic lipids were formulated into cationic liposomes with the neutral co-lipid dioleoyl-L-alpha-phosphatidylethanolamine (DOPE) or with a recently reported neutral lipophosphoramidate derivative of histamine (MM27). We observe that cationic liposomes prepared from the cationic lipid N',N'-dioctadecyl-N-4,8-diaza-10-aminodecanoylglycine amide (DODAG) and DOPE frequently mediate the highest levels of transfection in vitro in all three different cell lines studied (OVCAR-3, IGROV-1 and HeLa) both in the presence or absence of serum. In addition, in vitro cellular toxicity was found to be minimal. Alternatively, we observe that DODAG alone forms lipoplex nanoparticles with small interfering RNA (siRNA) that are able to mediate the functional delivery of two previously validated anti-hepatitis B virus (HBV)--siRNAs to murine liver in vivo with minimal observable liver toxicity and immune stimulation. Specific knock-down of HBV infection parameters (virion and hepatic mRNA levels) is observed that is at least equivalent to the impact of extensive treatment with lamivudine (a licensed antiviral drug). Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969034     DOI: 10.1016/j.jconrel.2009.12.001

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations.

Authors:  Xinmei Wang; Bo Yu; Wei Ren; Xiaokui Mo; Chenguang Zhou; Hongyan He; Huliang Jia; Lu Wang; Samson T Jacob; Robert J Lee; Kalpana Ghoshal; L James Lee
Journal:  J Control Release       Date:  2013-10-08       Impact factor: 9.776

2.  Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles.

Authors:  Won Ho Kong; Ki Hyun Bae; Sung Duk Jo; Jee Seon Kim; Tae Gwan Park
Journal:  Pharm Res       Date:  2011-08-13       Impact factor: 4.200

Review 3.  Lipid-based vectors for siRNA delivery.

Authors:  Shubiao Zhang; Defu Zhi; Leaf Huang
Journal:  J Drug Target       Date:  2012-09-20       Impact factor: 5.121

Review 4.  Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines.

Authors:  Jinho Park; Joonyoung Park; Yihua Pei; Jun Xu; Yoon Yeo
Journal:  Adv Drug Deliv Rev       Date:  2015-12-10       Impact factor: 15.470

Review 5.  Intratumoral drug delivery with nanoparticulate carriers.

Authors:  Hillary Holback; Yoon Yeo
Journal:  Pharm Res       Date:  2011-01-07       Impact factor: 4.200

6.  Lipid-like nanomaterials for simultaneous gene expression and silencing in vivo.

Authors:  Yizhou Dong; Ahmed A Eltoukhy; Christopher A Alabi; Omar F Khan; Omid Veiseh; J Robert Dorkin; Sasilada Sirirungruang; Hao Yin; Benjamin C Tang; Jeisa M Pelet; Delai Chen; Zhen Gu; Yuan Xue; Robert Langer; Daniel G Anderson
Journal:  Adv Healthc Mater       Date:  2014-03-13       Impact factor: 9.933

7.  Post-coupling strategy enables true receptor-targeted nanoparticles.

Authors:  Jianmeizi Chen; Michael R Jorgensen; Maya Thanou; Andrew D Miller
Journal:  J RNAi Gene Silencing       Date:  2011-09-15

Review 8.  Current progress in gene delivery technology based on chemical methods and nano-carriers.

Authors:  Lian Jin; Xin Zeng; Ming Liu; Yan Deng; Nongyue He
Journal:  Theranostics       Date:  2014-01-15       Impact factor: 11.556

Review 9.  Lipophilic Polyamines as Promising Components of Liposomal Gene Delivery Systems.

Authors:  Pavel A Puchkov; Michael A Maslov
Journal:  Pharmaceutics       Date:  2021-06-21       Impact factor: 6.321

10.  Lipid-based nanoparticles in cancer diagnosis and therapy.

Authors:  Andrew D Miller
Journal:  J Drug Deliv       Date:  2013-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.